Position in ARVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$98,224
+$25,402 QoQ
Shares Held
11,820
+72.1% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#143
of 201 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $1,111,483,806 across 123 Biotechnology names. ARVN ranks #118 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,483 | $104,553,220 | |
| 2 | INSM |
INSMED Inc
|
702,951 | $74,948,635 | |
| 3 | ABVX |
Abivax S.A.
|
504,471 | $67,225,805 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
760,977 | $56,677,566 | |
| 5 | ARGX |
Argenx SE
|
52,027 | $48,269,089 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
508,056 | $41,442,127 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
591,815 | $33,621,010 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
579,052 | $31,847,860 |
All Filings in ARVN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $98,224 | 11,820 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $72,822 | 6,870 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $81,478 | 6,870 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $237,026 | 27,820 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $272,099 | 36,970 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $259,529 | 36,970 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $570,690 | 29,770 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $613,779 | 24,920 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $659,377 | 24,770 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,022,505 | 24,770 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,070,983 | 26,020 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $511,032 | 26,020 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $593,694 | 23,920 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $633,004 | 23,170 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,614,115 | 105,645 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,190,735 | 94,195 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,516,645 | 59,792 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,812,970 | 86,374 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $6,710,180 | 81,692 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,279,673 | 27,740 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,575,649 | 46,437 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $330,500 | 5,000 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $424,650 | 5,000 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||